Retrievable Vena Cava Filter Market Global Report 2026

The retrievable vena cava filter market size has grown strongly in recent years. It will grow from $1.07 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing incidence of deep vein thrombosis, rising prevalence of pulmonary embolism cases, growing number of trauma and critical care patients, expanding use of interventional radiology procedures, increasing awareness regarding venous thromboembolism prevention.

The retrievable vena cava filter market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive vascular interventions, increasing adoption of retrievable and bioconvertible filter technologies, rising aging population at risk of thromboembolic disorders, expanding access to specialized vascular care services, growing investments in advanced cardiovascular medical devices. Major trends in the forecast period include increasing adoption of retrievable filters over permanent filter alternatives, growing preference for low profile filter designs to support minimally invasive procedures, rising development of advanced retrieval mechanisms to improve filter removal success rates, expanding utilization of convertible and optional vena cava filters in high risk patients, growing focus on reducing long term complications associated with filter implantation.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the retrievable vena cava filter market in the coming years. Cardiovascular diseases are a group of conditions that affect the heart and blood vessels, including coronary artery disease, stroke, deep vein thrombosis, and pulmonary embolism, which may result in serious complications and mortality if not properly managed. The prevalence of cardiovascular diseases is increasing due to the growing adoption of sedentary lifestyles, as limited physical activity contributes to obesity, hypertension, elevated cholesterol levels, and impaired blood circulation, which are major risk factors for heart disease and stroke. Retrievable vena cava filters are used in cardiovascular conditions to temporarily prevent blood clots from moving through the veins to the lungs, thereby lowering the risk of pulmonary embolism in patients with venous thromboembolism or those who cannot undergo anticoagulant therapy. For instance, in September 2025, according to the Heart Failure Epidemiology and Outcomes Statistics, a US-based cardiovascular research organization, the number of Americans living with heart failure was estimated at 6.7 million in 2024 and is expected to reach 8.7 million by 2030. Therefore, the increasing prevalence of cardiovascular diseases is contributing to the growth of the retrievable vena cava filter market.

The increasing healthcare expenditure is expected to drive the growth of the retrievable vena cava filter market in the coming years. Healthcare expenditure refers to the overall spending on healthcare products and services, including hospital care, physician services, medical devices, and preventive healthcare initiatives. Healthcare expenditure is increasing due to the rising burden of chronic diseases, as long-term disease management, regular monitoring, advanced medical procedures, and extended medication requirements significantly raise healthcare costs. Retrievable vena cava filters benefit from increased healthcare spending by allowing hospitals and healthcare providers to implement advanced clot-prevention devices for the management of deep vein thrombosis and pulmonary embolism among high-risk patients. For instance, in January 2026, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, physician and clinical services expenditures increased by 8.1% to $1.10 trillion in 2024, representing faster spending growth compared to the 7.4% rise recorded in 2023. Therefore, the increasing healthcare expenditure is supporting the growth of the retrievable vena cava filter market.

The increasing number of trauma and accident cases is expected to drive the growth of the retrievable vena cava filter market in the coming years. Trauma and accident cases refer to injuries caused by road traffic accidents, falls, workplace incidents, violence, or other physical events that result in severe bodily damage and require immediate medical attention. The number of trauma and accident cases is increasing mainly due to the rising volume of road traffic worldwide, fueled by rapid urbanization and increased vehicle ownership, which raises the risk of collisions and severe injuries. Retrievable vena cava filters are used in trauma and accident cases to temporarily prevent blood clots from traveling from deep veins to the lungs, thereby reducing the risk of pulmonary embolism in patients who are immobilized, critically injured, or unable to receive anticoagulant treatment. For instance, in January 2026, according to the International Transport Forum, a France-based intergovernmental organization, France recorded 3,193 road fatalities in 2024, representing an increase of 26 deaths compared to 2023. Therefore, the increasing number of trauma and accident cases is contributing to the growth of the retrievable vena cava filter market.

Major companies operating in the retrievable vena cava filter market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun SE, Cook Medical LLC, Cordis Corporation, Argon Medical Devices Inc., Lifetech Scientific Corporation, Bio2 Medical Inc., ALN Implants Chirurgicaux, Rex Medical L.P.

North America was the dominating region in the retrievable vena cava filter market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the retrievable vena cava filter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the retrievable vena cava filter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.